Role of FGF/FGFR Signaling in Skeletal Development and Homeostasis: Learning from Mouse Models

Overview

Journal Bone Res

Specialties Endocrinology
Orthopedics

Date 2015 Aug 15

PMID 26273516

Citations 125

Authors

Nan Su

Min Jin

Lin Chen

Affiliations

Soon will be listed here.

Abstract

Fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) signaling plays essential roles in bone development and diseases. Missense mutations in FGFs and FGFRs in humans can cause various congenital bone diseases, including chondrodysplasia syndromes, craniosynostosis syndromes and syndromes with dysregulated phosphate metabolism. FGF/FGFR signaling is also an important pathway involved in the maintenance of adult bone homeostasis. Multiple kinds of mouse models, mimicking human skeleton diseases caused by missense mutations in FGFs and FGFRs, have been established by knock-in/out and transgenic technologies. These genetically modified mice provide good models for studying the role of FGF/FGFR signaling in skeleton development and homeostasis. In this review, we summarize the mouse models of FGF signaling-related skeleton diseases and recent progresses regarding the molecular mechanisms, underlying the role of FGFs/FGFRs in the regulation of bone development and homeostasis. This review also provides a perspective view on future works to explore the roles of FGF signaling in skeletal development and homeostasis.

Citing Articles

Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy.

Chen J, He D, Yuan C, Li N, Shi B, Niu C J Orthop Translat. 2025; 51:68-81.

PMID: 39991457 PMC: 11847030. DOI: 10.1016/j.jot.2025.01.011.

Targeted allele-specific knockdown human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome.

Tiberio F, Salvati M, Polito L, Tisci G, Vita A, Parolini O Mol Ther Nucleic Acids. 2025; 36(1):102427.

PMID: 39906733 PMC: 11790506. DOI: 10.1016/j.omtn.2024.102427.

Genetic profiling of osteosarcoma in an adolescent using a next‑generation sequencing panel and Sanger sequencing: A case report and review of the literature.

Chantre-Justino M, Silvestre R, De Castro T, Luz E, Pinheiro R, Caruso A Biomed Rep. 2025; 22(3):42.

PMID: 39810900 PMC: 11729137. DOI: 10.3892/br.2025.1920.

The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23.

Lee S, Kim J, Ihn H, Choi J, Kwon T, Shin H Exp Mol Med. 2024; 56(11):2436-2448.

PMID: 39482539 PMC: 11612488. DOI: 10.1038/s12276-024-01341-9.

Genome-wide association studies for pelvic organ prolapse in the Japanese population.

Matsunami M, Imamura M, Ashikari A, Liu X, Tomizuka K, Hikino K Commun Biol. 2024; 7(1):1188.

PMID: 39349682 PMC: 11443051. DOI: 10.1038/s42003-024-06875-2.

References

Colvin J, Green R, Schmahl J, Capel B, Ornitz D . Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell. 2001; 104(6):875-89. DOI: 10.1016/s0092-8674(01)00284-7. View

Ornitz D, Marie P . FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002; 16(12):1446-65. DOI: 10.1101/gad.990702. View

Larsson T, Yu X, Davis S, Draman M, Mooney S, Cullen M . A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab. 2005; 90(4):2424-7. DOI: 10.1210/jc.2004-2238. View

Wang Y, Sun M, Uhlhorn V, Zhou X, Peter I, Martinez-Abadias N . Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. BMC Dev Biol. 2010; 10:22. PMC: 2838826. DOI: 10.1186/1471-213X-10-22. View

Clinkenbeard E, Farrow E, Summers L, Cass T, Roberts J, Bayt C . Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res. 2013; 29(2):361-9. PMC: 5240191. DOI: 10.1002/jbmr.2049. View

Usui H, Shibayama M, Ohbayashi N, Konishi M, Takada S, Itoh N . Fgf18 is required for embryonic lung alveolar development. Biochem Biophys Res Commun. 2004; 322(3):887-92. DOI: 10.1016/j.bbrc.2004.07.198. View

De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C . An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 2000; 127(3):483-92. DOI: 10.1242/dev.127.3.483. View

Peng H, Myers J, Fang X, Stachowiak E, Maher P, Martins G . Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J Neurochem. 2002; 81(3):506-24. DOI: 10.1046/j.1471-4159.2002.00833.x. View

Segev O, Chumakov I, Nevo Z, Givol D, Sheinin Y, Weinreb M . Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum Mol Genet. 1999; 9(2):249-58. DOI: 10.1093/hmg/9.2.249. View

10.

Gutierrez O, Januzzi J, Isakova T, Laliberte K, Smith K, Collerone G . Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119(19):2545-52. PMC: 2740903. DOI: 10.1161/CIRCULATIONAHA.108.844506. View

11.

Murakami H, Okawa A, Yoshida H, Nishikawa S, Moriya H, Koseki H . Elbow knee synostosis (Eks): a new mutation on mouse Chromosome 14. Mamm Genome. 2002; 13(7):341-4. DOI: 10.1007/s00335-001-2143-6. View

12.

Sobue T, Naganawa T, Xiao L, Okada Y, Tanaka Y, Ito M . Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J Cell Biochem. 2005; 95(1):83-94. DOI: 10.1002/jcb.20389. View

13.

Iwata T, Chen L, Li C, Ovchinnikov D, Behringer R, Francomano C . A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet. 2000; 9(11):1603-13. DOI: 10.1093/hmg/9.11.1603. View

14.

Govindarajan V, Overbeek P . FGF9 can induce endochondral ossification in cranial mesenchyme. BMC Dev Biol. 2006; 6:7. PMC: 1395304. DOI: 10.1186/1471-213X-6-7. View

15.

Passos-Bueno M, Wilcox W, Jabs E, Sertie A, Alonso L, Kitoh H . Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat. 1999; 14(2):115-25. DOI: 10.1002/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2. View

16.

Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T . Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 2000; 105(8):1085-93. PMC: 300831. DOI: 10.1172/JCI8641. View

17.

Mundy G . Osteoporosis and inflammation. Nutr Rev. 2008; 65(12 Pt 2):S147-51. DOI: 10.1111/j.1753-4887.2007.tb00353.x. View

18.

Kim H, Rice D, Kettunen P, Thesleff I . FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development. 1998; 125(7):1241-51. DOI: 10.1242/dev.125.7.1241. View

19.

Mirza M, Larsson A, Melhus H, Lind L, Larsson T . Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis. 2009; 207(2):546-51. DOI: 10.1016/j.atherosclerosis.2009.05.013. View

20.

Lin Y, Liu G, Wang F . Generation of an Fgf9 conditional null allele. Genesis. 2006; 44(3):150-4. DOI: 10.1002/gene.20194. View